Company

Revenio Group Oyj

Headquarters: Vantaa, Finland

Employees: 184

OMXH: REG1V +2.40%

Market Cap

€687.7 Million

EUR as of Jan. 1, 2024

US$759.5 Million

Market Cap History

Revenio Group Oyj market capitalization over time

Evolution of Revenio Group Oyj market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Revenio Group Oyj

Detailed Description

Revenio Group Oyj, a health technology company, designs, manufactures, and sells medical instruments for the early detection of glaucoma, diabetic retinopathy, and macular degeneration in Finland, Italy, rest of Europe, the United States, and internationally. The company offers ic100 and ic200 tonometers; Icare HOME, a device for self-measurement of eye pressure; Icare TONOVET Plus tonometers for animals; fundus imaging devices comprising EIDON, DRS, and DRSplus; MAIA, a microperimeter to measure the effectiveness of drugs for retinal disease treatment; COMPASS, which provides fundus perimetry with true-color confocal retinal images; and Ventica, to examine the variability in tidal breathing in children. It is also developing Cutica, a hyperspectral camera for dermatologists to detect skin cancers. Revenio Group Oyj is based in Vantaa, Finland.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Revenio Group Oyj has the following listings and related stock indices.


Stock: OMXH: REG1V wb_incandescent

Stock: Munich: R0V wb_incandescent

Details

Headquarters:

Aeyritie 22

Vantaa, 01510

Finland

Phone: 358 9877 51150